ClinicalTrials.Veeva

Menu

Transthoracic Echocardiography of the Superior Vena Cava in Intensive Care Units (ICU) Intubated Patients (CAVSUP)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Unknown

Conditions

Admission in Intensive Care Unit
Intubated Patients

Treatments

Other: Passive leg raising (PLR)
Device: Echo-Doppler measurements

Study type

Interventional

Funder types

Other

Identifiers

NCT03508401
69HCL17_0549

Details and patient eligibility

About

Acute circulatory failure is frequent, affecting up to one-third of patients admitted to intensive care units (ICU). Monitoring hemodynamics and cardiac function is therefore a major concern. Analysis of respiratory diameter variations of the superior vena cava (SVC) is easily obtained with transesophageal echocardiography (TEE) and is helpful to assess fluid responsiveness.

Transthoracic echocardiography (TTE) exploration of the SVC is not used in routine. Recently, micro-convex ultrasound transducers have been marketed and these may be of use for non-invasive SVC flow examination. However, analysis of diameter variations of the SVC with TTE does not seem to be possible since the approach from the supraclavicular fossa does not allow for a good visualization of the SVC walls.

It was recently demonstrated in a short pilot study that TTE examination of the SVC flow with a micro-convex ultrasound transducer (GE 8C-RS) seems both easy to learn and to use (feasibility = 84.9%), and is reproducible in most ventilated ICU patients with an intraclass correlation coefficient for the systolic fraction of the superior vena cava flow of 0.90 (95% confidence interval [0.86-0.93]).

The hypothesis is that cardio-respiratory interactions in intubated-ventilated patients are responsible of SVC flow variations and that the analysis of the SVC flow respiratory variations could be a new predictive tool of fluid responsiveness.

Enrollment

188 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients (≥ 18 years old)
  • Admission in ICU after tracheal intubation or tracheal intubation during the ICU stay
  • Volume-controlled ventilation with a tidal volume of 8 mL/kg
  • Patient or family agreement for the inclusion

Exclusion criteria

  • Persistence of spontaneous breathing
  • Cardiac arrhythmia
  • Severe Acute Respiratory Distress Syndrome, defined as PaO2/FIO2 ratio < 100
  • Acute right ventricular failure defined by S'VD < 10 cm or Tricuspid Annular Plane Systolic Excursion (TAPSE) < 10 mm measured with Transthoracic Echocardiography (TTE)

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

188 participants in 1 patient group

ICU intubated patients
Experimental group
Description:
After inclusion, Echo-Doppler measurements are performed with Vivid S6 model (GE Healthcare France, Lyon, France). The left ventricular outflow tract velocity time index (LVOT TVI) will be measured with this device. Then, a passive leg raising (PLR) will be performed and finally LVOT VTI will be measured again after PLR Patients will be classified in two groups according to the hemodynamic response to PLR : * Patients are responders if LVOT VTI increases of at least 10% after PLR * patients are non-responders if LVOT VTI does not increase or increase of less than 10% after PLR.
Treatment:
Device: Echo-Doppler measurements
Other: Passive leg raising (PLR)

Trial contacts and locations

1

Loading...

Central trial contact

Bertrand DEVIGNE, M.D, PhD; Guillaume MARCOTTE, M.D, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems